[(3R,5S,6R,7S,10S,11S)-21-(allylamino)-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate

ID: ALA4649689

Chembl Id: CHEMBL4649689

PubChem CID: 156022228

Max Phase: Preclinical

Molecular Formula: C37H53N3O13

Molecular Weight: 747.84

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O

Standard InChI:  InChI=1S/C37H53N3O13/c1-8-12-39-28-22-13-18(2)14-26(50-7)34(52-36-32(46)31(45)30(44)27(17-41)51-36)21(5)15-20(4)33(53-37(38)48)25(49-6)11-9-10-19(3)35(47)40-23(29(22)43)16-24(28)42/h8-11,15-16,18,21,25-27,30-34,36,39,41,44-46H,1,12-14,17H2,2-7H3,(H2,38,48)(H,40,47)/b11-9-,19-10+,20-15+/t18-,21+,25+,26+,27-,30-,31+,32-,33+,34-,36+/m1/s1

Standard InChI Key:  HFXJMPSEDMJGBM-KQOVDUKSSA-N

Alternative Forms

  1. Parent:

    ALA4649689

    ---

Associated Targets(Human)

CNE2Z (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMMC-7721 (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW480 (6023 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP90AA1 Tchem Heat shock protein HSP90 (3606 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 747.84Molecular Weight (Monoisotopic): 747.3578AlogP: 0.36#Rotatable Bonds: 9
Polar Surface Area: 245.43Molecular Species: NEUTRALHBA: 14HBD: 7
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.11CX Basic pKa: CX LogP: 0.79CX LogD: 0.79
Aromatic Rings: Heavy Atoms: 53QED Weighted: 0.12Np Likeness Score: 2.42

References

1. Li HM, Li B, Sun X, Ma H, Zhu M, Dai Y, Ma T, Li Y, Hong YS, Wu CZ..  (2020)  Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.,  30  (15): [PMID:32527461] [10.1016/j.bmcl.2020.127282]

Source